Global Top 10 Medical Devices Market (2010 - 2015)

Date: July 22, 2011
Pages: 575
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GBDD0D5AFB2EN
Leaflet:

Download PDF Leaflet

Global Top 10 Medical Devices Market (2010 - 2015)
The study of global top 10 medical devices market is important mainly due to continuous technological advancements in the medical devices industry and rising demand for medical devices owing to increasing healthcare issues. This report not only provides a full estimate of the global top 10 medical device technologies market but also gives a detailed analysis of their most critical micro-markets, which have remained unexplored so far. The medical devices market is a major contributor to the overall healthcare industry with the pharmaceuticals industry leading the healthcare sector. The rising incidence of various diseases in the areas of Cardiovascular devices (CVD), respiratory, oncology, neurology, and many others have expanded the need for faster and better medical devices for treatment and diagnosis.

The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry

Scope of the report

This research report includes following segments:
  • Cardiovascular devices
  • Orthopedics devices
  • Diagnostic imaging devices
  • Minimally invasive devices
  • Diabetes devices
  • Anesthesia and respiratory care devices
  • Dialysis products
  • Ophthalmology devices
  • Patient monitoring devices
  • Point-of-care diagnostic devices
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report provides more than 30 company profiles covering all the sub-segments.

What makes our reports unique?
  • We provide the longest market segmentation chain in this industry.
  • We provide 10% customization. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps, and opportunities are identified for all the stakeholders.
  • Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishing and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
EXECUTIVE SUMMARY

OBJECTIVE
MARKET SCENARIO

1 INTRODUCTION

1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY

2 SUMMARY


3 MARKET OVERVIEW

3.1 INTRODUCTION
3.2 DEFINITION OF TOP 10 MEDICAL DEVICES MARKET
3.3 DRIVERS
  3.3.1 AGING POPULATION IS A MAJOR GROWTH FACTOR
  3.3.2 ACCEPTANCE OF NEWER TECHNOLOGIES BY THE PHYSICIANS
  3.3.3 OUTSOURCING OF MEDICAL EQUIPMENT
3.4 RESTRAINTS
  3.4.1 U.S. HEALTHCARE REFORM IMPACTING THE MEDICAL DEVICE COMPANIES
    3.4.1.1 Excise tax
    3.4.1.2 Reduction in hospital orders
3.5 OPPORTUNITIES
  3.5.1 RAPID GROWTH IN EMERGING MARKETS
  3.5.2 SECTORAL GROWTH IS EXPECTED POST IMPLEMENTATION OF REFORMS
3.6 MEDICAL DEVICES MARKET SHARE
3.7 MARKET DOMINANCE OF U.S. MANUFACTURERS
3.8 HIGHER VISIBILITY OF CORE MEDICAL DEVICES COMPANIES
3.9 CARDIOVASCULAR & ORTHOPEDICS DEVICES LEADING THE MARKET
3.1 PATENT ANALYSIS
  3.10.1 DEVICE MANUFACTURERS FOCUSING ON RESPIRATORY DEVICES & PATIENT MONITORING
  3.10.2 KEY INDUSTRIAL PARTICIPANTS FOCUSING ON IMAGING AND DIALYSIS

4 DIAGNOSTIC IMAGING

4.1 INTRODUCTION
4.2 DRIVERS
  4.2.1 NEW TECHNOLOGIES FOR DIAGNOSTIC IMAGING ENHANCE THE MARKET GROWTH
  4.2.2 EXPANDING APPLICATIONS FOR DIAGNOSTIC IMAGING
4.3 BURNING ISSUES
  4.3.1 FDA INTERVENTION IN MEDICAL IMAGING TESTS
4.4 MARKET SHARE
4.5 ULTRASOUND
  4.5.1 DRIVERS
    4.5.1.1 Demand from emerging markets drives the ultrasound devices growth
    4.5.1.2 Increasing use of ultrasound equipment by non-radiologists & for emergency medicine
  4.5.2 APPLICATION AREAS FOR ULTRASOUND IMAGING
  4.5.3 MARKET SHARE
4.6 X-RAY
  4.6.1 DRIVERS
    4.6.1.1 Digital radiography boosts the overall X-ray equipment market
    4.6.1.2 Mammography diagnosis supports the X-ray equipment growth
4.7 NUCLEAR IMAGING
4.8 MRI
4.9 COMPUTED TOMOGRAPHY (CT)

5 CARDIOVASCULAR DEVICES

5.1 INTRODUCTION
5.2 DRIVERS & RESTRAINTS
  5.2.1 DEMOGRAPHIC FACTORS PROPELLING THE GROWTH
  5.2.2 NEW TECHNOLOGIES TAKING THE MARKET AHEAD
  5.2.3 HIGH DEGREE OF COMPETITION
5.3 BURNING ISSUE
  5.3.1 ECG ON A MOVE
5.4 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES
5.5 CARDIAC RHYTHM MANAGEMENT DEVICES
5.6 INTERVENTION CARDIOLOGY
5.7 PERIPHERAL VASCULAR DEVICES
5.8 PROSTHETIC DEVICES
5.9 CARDIAC SURGERY DEVICES
5.10 ELECTROPHYSIOLOGY

6 PATIENT MONITORING DEVICES

6.1 INTRODUCTION
6.2 DRIVERS & RESTRAINTS
  6.2.1 TECHNOLOGICAL ADVANCES FUELING THE GROWTH
  6.2.2 EMERGING MARKETS DRIVING THE GROWTH
  6.2.3 LOW COST MANUFACTURERS
6.3 WINNING IMPERATIVE
  6.3.1 WIRELESS TECHNOLOGY DIFFERENTIATING THE PLAYERS
6.4 PATIENT MONITORS
6.5 VITAL SIGN MONITORS
6.6 FETAL & NEONATAL MONITORS
6.7 ANESTHESIA MONITORS

7 OPHTHALMOLOGY DEVICES

7.1 INTRODUCTION
7.2 DRIVERS
  7.2.1 INCREASING INCIDENCE OF OPHTHALMOLOGY DISEASES
  7.2.2 TECHNOLOGICAL ADVANCES DRIVING THE MARKET
7.3 RESTRAINTS
  7.3.1 HIGH COST OF TREATMENT
  7.3.2 LACK OF REIMBURSEMENT FOR LASER PROCEDURES
7.4 WINNING IMPERATIVES
  7.4.1 POSITIONING THE PRODUCT PROPERLY GIVES A COMPETITIVE EDGE
7.5 CATARACT DEVICES
  7.5.1 INTRAOCULAR LENS
  7.5.2 PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES
7.6 REFRACTIVE ERROR
  7.6.1 CONTACT LENS
  7.6.2 EXCIMER LASER

8 MINIMALLY INVASIVE SURGICAL DEVICES, BY SURGERY

8.1 INTRODUCTION
8.2 DRIVERS & RESTRAINTS
  8.2.1 MANY ADVANTAGES OF NON-INVASIVE SURGERY
  8.2.2 HIGH INITIAL COST
  8.2.3 RESTRICTED PATIENT APPLICABILITY
8.3 TRENDS
  8.3.1 INCREASING USE OF SHAPE MEMORY ALLOY
8.4 WINNING IMPERATIVES
  8.4.1 INNOVATION IS THE KEY TO SUCCESS
8.5 CARDIOTHORACIC SURGERY
8.6 ORTHOPEDIC SURGERY
8.7 GASTROINTESTINAL SURGERY
8.8 GYNECOLOGY SURGERY

9 KIDNEY/DIALYSIS DEVICES

9.1 INTRODUCTION
9.2 DRIVERS
  9.2.1 INCREASE IN THE CASES OF CHRONIC KIDNEY DISEASES
  9.2.2 LESS NUMBER OF DONORS FOR RENAL TRANSPLANTS
9.3 RESTRAINTS
  9.3.1 LOW PENETRATION IN DEVELOPING MARKET
  9.3.2 MARKET DOMINATED BY FEW LARGE PLAYERS
9.4 WINNING IMPERATIVE
  9.4.1 INTEGRATION HELPS IN CUTTING DOWN THE COST
9.5 HEMODIALYSIS PRODUCTS
9.6 PERITONEAL DIALYSIS PRODUCTS

10 POINT-OF-CARE DIAGNOSTIC DEVICES

10.1 INTRODUCTION
10.2 DRIVERS & RESTRAINTS
  10.2.1 SELF TESTING GIVING THE MOMENTUM
  10.2.2 MANY ADVANTAGES OF POINT-OF-CARE TESTING
  10.2.3 HIGHLY FRAGMENTED INDUSTRY
10.3 BLOOD GLUCOSE MONITORING
10.4 BLOOD CHEMISTRY & ELECTROLYTE
10.5 PREGNANCY/FERTILITY
10.6 CARDIOLOGY
10.7 DRUG OF ABUSE MEASURING DEVICES
10.8 INFECTIOUS DISEASES

11 ANESTHESIA & RESPIRATORY CARE DEVICES

11.1 INTRODUCTION
11.2 DRIVERS & RESTRAINTS
  11.2.1 TECHNOLOGY ADVANCEMENTS
  11.2.2 COMPETITIVE PRICING BY OEMS
11.3 OPPORTUNITIES
  11.3.1 MEDICAL TOURISM
11.4 BURNING ISSUES
  11.4.1 U.S. HEALTH REFORMS TO IMPACT THE MARKET FOR ANESTHESIA & RESPIRATORY DEVICES
  11.4.2 INFORMATION TECHNOLOGY IN RESPIRATORY & ANESTHESIA DEVICES
11.5 ANESTHESIA DEVICES
  11.5.1 ANESTHESIA MACHINES
    11.5.1.1 Workstations
    11.5.1.2 Delivery machines
    11.5.1.3 Ventilators
    11.5.1.4 Monitors
  11.5.2 ANESTHESIA DISPOSABLES
    11.5.2.1 Endotracheal tubes
    11.5.2.2 Anesthesia gas masks
    11.5.2.3 Anesthesia breathing circuits
11.6 RESPIRATORY CARE DEVICES
  11.6.1 DRIVERS
    11.6.1.1 High prevalence of respiratory diseases
    11.6.1.2 Changing lifestyle & increasing number of smokers
    11.6.1.3 Growing number of aged people
    11.6.1.4 Technological advancements
  11.6.2 RESTRAINTS
    11.6.2.1 Economic slowdown
  11.6.3 KEY TRENDS
    11.6.3.1 Emerging economies demand cost-efficient equipment
    11.6.3.2 More focus on compact devices for diagnostics
  11.6.4 RESPIRATORY CARE THERAPEUTICS DEVICES
    11.6.4.1 Drivers
      11.6.4.1.1 Home healthcare growth has led to increased demand for therapeutic devices
      11.6.4.1.2 User-friendly systems & technology increases the adoption of devices
    11.6.4.2 Restraints
      11.6.4.2.1 Market saturation
      11.6.4.2.2 High cost of ownership restricts the adoption of devices
    11.6.4.3 Opportunities
      11.6.4.3.1 Used in delivery of Vaccines, Systemic Therapy & Gene-replacement Therapy
    11.6.4.4 Burning issues
      11.6.4.4.1 Ban on chlorofluorocarbon based Propellants
      11.6.4.4.2 Reduction in the reimbursement amount for Home Oxygen
    11.6.4.5 Winning imperatives
      11.6.4.5.1 Lower operating costs & packaging give a long-term advantage
      11.6.4.5.2 Portability is a key distinguishing feature
    11.6.4.6 Humidifiers
      11.6.4.6.1 Heated Humidifiers
      11.6.4.6.2 Passover Humidifiers
    11.6.4.7 Further classification of heated & passover humidifiers
      11.6.4.7.1 Integrated humidifiers
      11.6.4.7.2 Built-in humidifiers
      11.6.4.7.3 Stand alone humidifiers
    11.6.4.8 Nebulizers
      11.6.4.8.1 Compressor-based Nebulizers
      11.6.4.8.2 Piston-based hand held nebulizers
      11.6.4.8.3 Ultrasonic nebulizers
    11.6.4.9 Oxygen concentrators
      11.6.4.9.1 Fixed oxygen concentrators
      11.6.4.9.2 Portable oxygen concentrators
    11.6.4.10 Positive Airway Pressure (PAP) devices
      11.6.4.10.1 Continuous Positive Airway Pressure (CPAP) devices
      11.6.4.10.2 Other PAP devices market
    11.6.4.11 Reusable resuscitators
    11.6.4.12 Ventilators
      11.6.4.12.1 Adult Ventilators
      11.6.4.12.2 Neonatal Ventilators
    11.6.4.13 Respiratory inhalers
      11.6.4.13.1 Dry Powder Inhaler (DPI)
      11.6.4.13.2 Metered dose inhaler
  11.6.5 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES
    11.6.5.1 Drivers & restraints
      11.6.5.1.1 Rising importance of monitoring respiratory diseases
      11.6.5.1.2 High level of saturation in pulse oximeter
    11.6.5.2 Burning issues
      11.6.5.2.1 WHO initiation for developing cost effective oximeters
    11.6.5.3 Winning imperatives
      11.6.5.3.1 Pulse oximeter market players focusing on additional features to gain competitive edge
      11.6.5.3.2 Compactness of devices as a unique selling proposition
    11.6.5.4 Respiratory care monitoring devices
      11.6.5.4.1 Pulse oximeter
        11.6.5.4.1.1 Pulse oximeter equipment
        11.6.5.4.1.2 Handheld pulse oximeters
        11.6.5.4.1.3 Fingertip pulse oximeters
        11.6.5.4.1.4 Tabletop pulse oximeters
        11.6.5.4.1.5 Wrist worn pulse oximeters
        11.6.5.4.1.6 Pulse oximeter sensors
      11.6.5.4.2 Capnographs
      11.6.5.4.3 Gas analyzers
    11.6.5.5 Respiratory disposables
      11.6.5.5.1 Oxygen mask
      11.6.5.5.2 Resuscitators
      11.6.5.5.3 Tracheostomy tubes
      11.6.5.5.4 Oxygen Cannulae
  11.6.6 RESPIRATORY CARE DIAGNOSTIC DEVICES (RESPIRATORY MEASUREMENT DEVICES)
    11.6.6.1 Drivers & Restraints
      11.6.6.1.1 Developing economies emerging as fast growth markets for diagnostic technologist
      11.6.6.1.2 Complicated Reimbursements process in diagnostic segment
      11.6.6.1.3 Highly competitive
    11.6.6.2 Opportunities
      11.6.6.2.1 Point-of-care diagnostics an upcoming opportunity
    11.6.6.3 Burning issues & trends
      11.6.6.3.1 Spirometry in Toddlers/Infants a challenge
      11.6.6.3.2 Spirometer on iphone
    11.6.6.4 Winning imperatives
      11.6.6.4.1 Focus on accurate & clinically important information
    11.6.6.5 Spirometer
      11.6.6.5.1 Mechanical volume spirometers
      11.6.6.5.2 Automated flow spirometers
    11.6.6.6 Peak flow meters
    11.6.6.7 Recorders/polysomnography devices
    11.6.6.8 Other diagnostic devices
      11.6.6.8.1 Exercise testing equipment
      11.6.6.8.2 Pneumotachometer
        11.6.6.8.2.1 Fleisch type pneumotachometer
        11.6.6.8.2.2 Lilly type pneumotachometer
      11.6.6.8.3 Plethysmograph

12 DIABETES CARE DEVICES

12.1 INTRODUCTION
12.2 DRIVERS
  12.2.1 INCREASING OBESITY
  12.2.2 DEVELOPING ECONOMIES ARE PANDEMIC CENTERS OF DIABETES
12.3 RESTRAINTS
  12.3.1 AFFORDABILITY LIMITS THE GROWTH IN DEVELOPING COUNTRIES
  12.3.2 RIGID MIND SET OF HEALTHCARE PROVIDERS
12.4 WINNING IMPERATIVES
  12.4.1 KEY OPINION LEADERS HOLD THE KEY
  12.4.2 DISTRIBUTION IS THE BACKBONE TO SUCCESS
12.5 TRENDS
  12.5.1 COMBINATION OF FUNCTIONS
  12.5.2 DIABETES VACCINE & INHALABLE INSULIN
12.6 GLUCOSE MONITORING DEVICES
  12.6.1 BLOOD GLUCOSE TEST STRIPS
  12.6.2 BLOOD GLUCOSE METERS & LANCETS
12.7 INSULIN DELIVERY DEVICES

13 ORTHOPEDICS DEVICES

13.1 INTRODUCTION
13.2 DRIVERS
  13.2.1 ORTHOBIOLOGICS DRIVING THE INDUSTRY
  13.2.2 INCREASING REQUIREMENTS OF ORTHOPEDIC TRANSPLANTS
13.3 RESTRAINTS
  13.3.1 FEW MAJOR MARKET PLAYERS
  13.3.2 ECONOMIC SLOWDOWN
13.4 ORTHOBIOLOGICS
13.5 JOINT RECONSTRUCTION
13.6 SPINAL SURGERY DEVICES
13.7 TRAUMA FIXATION PRODUCTS
13.8 ARTHROSCOPIC DEVICES
13.9 ORTHOPEDIC ACCESSORIES
13.1 ORTHOPEDIC BRACES & SUPPORTS

14 GEOGRAPHIC ANALYSIS

14.1 INTRODUCTION
14.2 NORTH AMERICA
14.3 EUROPE
14.4 ASIA
14.5 ROW

15 COMPETITIVE LANDSCAPE

15.1 INTRODUCTION

16 COMPANY PROFILES

16.1 3M COMPANY
  16.1.1 OVERVIEW
  16.1.2 PRODUCTS & SERVICES
  16.1.3 FINANCIALS
  16.1.4 STRATEGY
  16.1.5 DEVELOPMENTS
16.2 ABBOTT LABORATORIES
  16.2.1 OVERVIEW
  16.2.2 PRODUCTS & SERVICES
  16.2.3 FINANCIALS
  16.2.4 STRATEGY
  16.2.5 DEVELOPMENTS
16.3 AGFA HEALTHCARE
  16.3.1 OVERVIEW
  16.3.2 PRODUCTS & SERVICES
  16.3.3 STRATEGY
  16.3.4 DEVELOPMENTS
16.4 ALCON
  16.4.1 OVERVIEW
  16.4.2 PRODUCTS & SERVICES
  16.4.3 FINANCIALS
  16.4.4 STRATEGY
  16.4.5 DEVELOPMENTS
16.5 ALLERGAN INC.
  16.5.1 OVERVIEW
  16.5.2 PRODUCTS & SERVICES
  16.5.3 FINANCIALS
  16.5.4 STRATEGY
  16.5.5 DEVELOPMENTS
16.6 B. BRAUN
  16.6.1 OVERVIEW
  16.6.2 PRODUCTS & SERVICES
  16.6.3 FINANCIALS
  16.6.4 STRATEGY
  16.6.5 DEVELOPMENTS
16.7 BAXTER INTERNATIONAL
  16.7.1 OVERVIEW
  16.7.2 PRODUCTS & SERVICES
  16.7.3 FINANCIALS
  16.7.4 STRATEGY
  16.7.5 DEVELOPMENTS
16.8 BECKMAN COULTER
  16.8.1 OVERVIEW
  16.8.2 PRODUCTS & SERVICES
  16.8.3 FINANCIALS
  16.8.4 STRATEGY
  16.8.5 DEVELOPMENTS
16.9 BECTON DICKINSON
  16.9.1 OVERVIEW
  16.9.2 PRODUCTS & SERVICES
  16.9.3 FINANCIALS
  16.9.4 STRATEGY
  16.9.5 DEVELOPMENTS
16.10 BIOMET
  16.10.1 OVERVIEW
  16.10.2 PRODUCTS & SERVICES
  16.10.3 FINANCIALS
  16.10.4 STRATEGY
  16.10.5 DEVELOPMENTS
16.11 BOSTON SCIENTIFIC CORPORATION
  16.11.1 OVERVIEW
  16.11.2 PRODUCTS & SERVICES
  16.11.3 FINANCIALS
  16.11.4 STRATEGY
  16.11.5 DEVELOPMENTS
16.12 C.R. BARD
  16.12.1 OVERVIEW
  16.12.2 PRODUCTS & SERVICES
  16.12.3 FINANCIALS
  16.12.4 STRATEGY
  16.12.5 DEVELOPMENTS
16.13 CARDINAL HEALTH
  16.13.1 OVERVIEW
  16.13.2 PRODUCTS & SERVICES
  16.13.3 FINANCIALS
  16.13.4 STRATEGY
  16.13.5 DEVELOPMENTS
16.14 COVIDIEN
  16.14.1 OVERVIEW
  16.14.2 PRODUCTS & SERVICES
  16.14.3 FINANCIALS
  16.14.4 STRATEGY
  16.14.5 DEVELOPMENTS
16.15 DANAHER
  16.15.1 OVERVIEW
  16.15.2 PRODUCTS & SERVICES
  16.15.3 FINANCIALS
  16.15.4 STRATEGY
  16.15.5 DEVELOPMENTS
16.16 DENTSPLY INTERNATIONAL
  16.16.1 OVERVIEW
  16.16.2 PRODUCTS & SERVICES
  16.16.3 FINANCIALS
  16.16.4 STRATEGY
  16.16.5 DEVELOPMENTS
16.17 FRESENIUS MEDICAL CARE
  16.17.1 OVERVIEW
  16.17.2 PRODUCTS & SERVICES
  16.17.3 FINANCIALS
  16.17.4 STRATEGY
  16.17.5 DEVELOPMENTS
16.18 GE HEALTHCARE
  16.18.1 OVERVIEW
  16.18.2 PRODUCTS & SERVICES
  16.18.3 STRATEGY
  16.18.4 DEVELOPMENTS
16.19 HITACHI MEDICAL CORPORATION
  16.19.1 OVERVIEW
  16.19.2 PRODUCTS & SERVICES
  16.19.3 FINANCIALS
  16.19.4 STRATEGY
  16.19.5 DEVELOPMENTS
16.20 HOSPIRA
  16.20.1 OVERVIEW
  16.20.2 PRODUCTS & SERVICES
  16.20.3 FINANCIALS
  16.20.4 STRATEGY
  16.20.5 DEVELOPMENTS
16.21 JOHNSON & JOHNSON
  16.21.1 OVERVIEW
  16.21.2 PRODUCTS & SERVICES
  16.21.3 FINANCIALS
  16.21.4 STRATEGY
  16.21.5 DEVELOPMENTS
16.22 MEDTRONIC INC.
  16.22.1 OVERVIEW
  16.22.2 PRODUCTS & SERVICES
  16.22.3 FINANCIALS
  16.22.4 STRATEGY
  16.22.5 DEVELOPMENTS
16.23 OLYMPUS CORPORATION
  16.23.1 OVERVIEW
  16.23.2 PRODUCTS & SERVICES
  16.23.3 FINANCIALS
  16.23.4 STRATEGY
16.24 PHILIPS HEALTHCARE
  16.24.1 OVERVIEW
  16.24.2 PRODUCTS & SERVICES
  16.24.3 FINANCIALS
  16.24.4 STRATEGY
  16.24.5 DEVELOPMENTS
16.25 SIEMENS HEALTHCARE
  16.25.1 OVERVIEW
  16.25.2 PRODUCTS & SERVICES
  16.25.3 STRATEGY
  16.25.4 DEVELOPMENTS
16.26 SMITH & NEPHEW
  16.26.1 OVERVIEW
  16.26.2 PRODUCTS & SERVICES
  16.26.3 FINANCIALS
  16.26.4 STRATEGY
  16.26.5 DEVELOPMENTS
16.27 ST. JUDE MEDICAL INC.
  16.27.1 OVERVIEW
  16.27.2 PRODUCTS & SERVICES
  16.27.3 FINANCIALS
  16.27.4 STRATEGY
  16.27.5 DEVELOPMENTS
16.28 STRYKER
  16.28.1 OVERVIEW
  16.28.2 PRODUCTS & SERVICES
  16.28.3 FINANCIALS
  16.28.4 STRATEGY
  16.28.5 DEVELOPMENTS
16.29 SYNTHES INC.
  16.29.1 OVERVIEW
  16.29.2 PRODUCTS & SERVICES
  16.29.3 FINANCIALS
  16.29.4 STRATEGY
  16.29.5 DEVELOPMENTS
16.3 TERUMO MEDICAL CORP
  16.30.1 OVERVIEW
  16.30.2 PRODUCTS & SERVICES
  16.30.3 STRATEGY
  16.30.4 DEVELOPMENTS
16.31 TOSHIBA
  16.31.1 OVERVIEW
  16.31.2 PRODUCTS & SERVICES
  16.31.3 FINANCIALS
  16.31.4 STRATEGY
  16.31.5 DEVELOPMENTS
16.32 ZIMMER HOLDINGS
  16.32.1 OVERVIEW
  16.32.2 PRODUCTS & SERVICES
  16.32.3 FINANCIALS
  16.32.4 STRATEGY
  16.32.5 DEVELOPMENTS

APPENDIX

? US PATENTS
? EUROPE PATENTS
? JAPAN PATENTS

LIST OF TABLES

TABLE 1 GLOBAL TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 2 GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 3 DIAGNOSTIC IMAGING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 4 GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 5 ULTRASOUND MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 6 X-RAY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 7 NUCLEAR IMAGING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 8 MRI MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 9 COMPUTED TOMOGRAPHY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 10 GLOBAL CARDIOVASCULAR DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 11 CARDIOVASCULAR DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 12 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 13 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 14 INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 15 PERIPHERAL VASCULAR DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 16 PROSTHETIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 17 CARDIAC SURGERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 18 ELECTROPHYSIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19 GLOBAL PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 20 PATIENT MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 21 PATIENT MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 22 VITAL SIGN MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 23 FETAL & NEONATAL MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 24 ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 25 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 26 OPHTHALMOLOGY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 27 GLOBAL CATARACT DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 28 CATARACT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 29 INTRAOCULAR LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30 PHACOEMULSIFICATION EQUIPMENT & VISCOELASTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 31 GLOBAL REFRACTIVE ERROR MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 32 REFRACTIVE ERROR MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 33 GLOBAL REFRACTIVE ERROR DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 34 CONTACT LENS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 35 EXCIMER LASER MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36 GLOBAL MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 37 MINIMALLY INVASIVE SURGICAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 38 CARDIOTHORACIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 39 ORTHOPEDIC SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 40 GASTROINTESTINAL SURGERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 41 GYNECOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42 GLOBAL DIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 43 DIALYSIS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 44 HEMODIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 45 PERITONEAL DIALYSIS PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 46 GLOBAL POC DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 47 POC DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 48 BLOOD GLUCOSE MONITORING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 49 BLOOD CHEMISTRY & ELECTROLYTE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 50 PREGNANCY/FERTILITY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 51 CARDIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 52 DRUG OF ABUSE MEASURING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 53 INFECTIOUS DISEASE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54 GLOBAL ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 55 ANESTHESIA & RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 56 GLOBAL ANESTHESIA DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 57 ANESTHESIA DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 58 GLOBAL ANESTHESIA MACHINES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 59 ANESTHESIA MACHINES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 60 GLOBAL ANESTHESIA MONITORS & WORKSTATIONS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 61 ANESTHESIA WORK STATIONS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 62 ANESTHESIA DELIVERY MACHINES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 63 ANESTHESIA VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 64 ANESTHESIA MONITORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 65 GLOBAL ANESTHESIA DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 66 ANESTHESIA DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 67 GLOBAL ANESTHESIA DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 68 ENDOTRACHEAL TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 69 ANESTHESIA GAS MASKS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 70 ANESTHESIA BREATHING CIRCUITS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 71 GLOBAL RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 72 RESPIRATORY CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 73 GLOBAL RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 74 RESPIRATORY CARE THERAPEUTICS DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 75 RESPIRATORY CARE THERAPEUTICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 76 GLOBAL HUMIDIFIERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 77 GLOBAL HUMIDIFIERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 78 HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 79 HEATED HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 80 PASSOVER HUMIDIFIERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 81 NEBULIZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 82 GLOBAL OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 83 GLOBAL OXYGEN CONCENTRATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 84 OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 86 PORTABLE OXYGEN CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 87 GLOBAL PAP DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 88 PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 89 CPAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 90 OTHER PAP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 91 REUSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 92 GLOBAL VENTILATORS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 93 GLOBAL VENTILATORS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 94 VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 95 ADULT VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 96 NEONATAL VENTILATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 97 GLOBAL RESPIRATORY INHALERS MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 98 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 99 RESPIRATORY INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 100 DRY POWDER INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 101 METERED DOSE INHALERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 102 GLOBAL RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 103 RESPIRATORY CARE MONITORING DEVICES & DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 104 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 105 GLOBAL RESPIRATORY CARE MONITORING DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 107 GLOBAL PULSE OXIMETRY MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 108 PULSE OXIMETRY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 109 PULSE OXIMETER EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 110 PULSE OXIMETER SENSORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 111 CAPNOGRAPHS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 112 GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 113 GLOBAL RESPIRATORY DISPOSABLES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 114 GLOBAL RESPIRATORY DISPOSABLES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 115 RESPIRATORY DISPOSABLES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 116 DISPOSABLE OXYGEN MASK MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 117 DISPOSABLE RESUSCITATORS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 118 TRACHEOSTOMY TUBES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 119 OXYGEN CANNULAE MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 120 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 121 GLOBAL RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 122 RESPIRATORY CARE DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 123 SPIROMETERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 124 PEAK FLOW METERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 125 POLYSOMNOGRAPHY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 126 OTHER DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 127 GLOBAL DIABETES CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 128 DIABETES CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 129 GLOBAL GLUCOSE MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 130 GLUCOSE MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 131 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET, BY PRODUCTS, 2008 – 2015 (UNIT SHIPMENTS IN THOUSANDS)
TABLE 132 BLOOD GLUCOSE TEST STRIPS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 133 BLOOD GLUCOSE METERS & LANCETS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 134 INSULIN DELIVERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 135 ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 136 ORTHOPEDICS DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 137 ORTHOBIOLOGICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 138 JOINT RECONSTRUCTION MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 139 SPINAL SURGERY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 140 TRAUMA FIXATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 141 ARTHROSCOPIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 142 ORTHOPEDIC ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 143 ORTHOPEDIC BRACES & SUPPORTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 144 TOP 10 MEDICAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 145 NORTH AMERICA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 146 EUROPE: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 147 ASIA: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 148 ROW: TOP 10 MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)
TABLE 149 AGREEMENTS & PARTNERSHIPS/CONTRACTS/ALLIANCES
TABLE 150 MERGER, ACQUISITION & COLLABORATION
TABLE 151 PRODUCT LAUNCH/PRODUCT INTEGRATION
TABLE 152 OTHER
TABLE 153 3M COMPANY: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 154 3M COMPANY: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 155 3M COMPANY: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 156 ABBOTT LABS: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 157 ABBOTT LABS: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 158 ABBOTT LABS: SALES, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 159 ALCON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 160 ALCON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 161 ALCON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 162 ALLERGAN INC.: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 163 ALLERGAN INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 164 ALLERGAN INC.: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)
TABLE 165 B. BRAUN: REVENUE AND R&D EXPENSES, 2008 – 2009 ($MILLION)
TABLE 166 B. BRAUN: MARKET REVENUE, BY GEOGRAPHY & BUSINESS SEGMENTS, 2009 ($MILLION)
TABLE 167 BAXTER INTERNATIONAL: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 168 BAXTER INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 169 BAXTER INTERNATIONAL: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 170 BECKMAN COULTER: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 171 BECKMAN COULTER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 172 BECKMAN COULTER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 173 BECTON DICKINSON: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 174 BECTON DICKINSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 175 BECTON DICKINSON: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 176 BIOMET: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 177 BIOMET: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 178 BIOMET: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 179 BOSTON SCIENTIFIC: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 180 BOSTON SCIENTIFIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 181 C.R. BARD: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 182 C.R. BARD: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 183 C.R. BARD: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 184 CARDINAL HEALTH: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 185 CARDINAL HEALTH: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 186 COVIDIEN: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 187 COVIDIEN: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 188 COVIDIEN: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 189 DANAHER: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 190 DANAHER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 191 DANAHER: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 192 DENTSPLY INTERNATIONAL: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 193 DENTSPLY INTERNATIONAL: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 194 DENTSPLY INTERNATIONAL: MARKET REVENUE, BY REGION, 2007 – 2009 ($MILLION)
TABLE 195 FRESENIUS MEDICAL CARE: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 196 FRESENIUS MEDICAL CARE: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 197 FRESENIUS MEDICAL CARE: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 198 HITACHI MEDICAL CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 199 HITACHI MEDICAL CORP: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 200 HITACHI MEDICAL CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 201 HOSPIRA: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 202 HOSPIRA: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 203 JOHNSON & JOHNSON: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 204 JOHNSON & JOHNSON: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 205 JOHNSON & JOHNSON: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 206 MEDTRONIC: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 207 MEDTRONIC: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 208 MEDTRONIC: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 209 OLYMPUS CORP: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 210 OLYMPUS CORP: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 211 OLYMPUS CORP: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 212 SMITH & NEPHEW: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 213 SMITH & NEPHEW: MARKET REVENUE, BY BUSINESS SEGMENTS, 2007 – 2009 ($MILLION)
TABLE 214 SMITH & NEPHEW: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 215 ST. JUDE MEDICAL INC.: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 216 ST. JUDE MEDICAL INC.: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 217 STRYKER: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 218 STRYKER: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 219 STRYKER: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 220 SYNTHES: REVENUE AND R&D EXPENSES, 2007 – 2009 ($MILLION)
TABLE 221 SYNTHES: MARKET REVENUE, BY GEOGRAPHY, 2007 – 2009 ($MILLION)
TABLE 222 TOSHIBA: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 223 TOSHIBA: MARKET REVENUE, BY BUSINESS SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 224 TOSHIBA: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 225 ZIMMER HOLDINGS: REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 226 ZIMMER HOLDINGS: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL TOP 10 MEDICAL DEVICES MARKET, BY SEGMENTS
FIGURE 2 TOP 10 MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 3 MEDICAL DEVICES MARKET SHARE WITH RESPECT TO TOP 30 MARKET PLAYERS (2009)
FIGURE 4 REGIONAL DOMINANCE OF TOP PLAYERS
FIGURE 5 PENETRATION OF TOP MARKET PLAYERS IN MEDICAL DEVICES INDUSTRY
FIGURE 6 SEGMENT STUDY FOR TOP 10 MEDICAL DEVICES MARKET
FIGURE 7 PATENTS BY SEGMENTS, 2007 – 2011
FIGURE 8 PATENTS BY MARKET PLAYERS, 2007 – 2011
FIGURE 9 GLOBAL DIAGNOSTIC IMAGING DEVICES: MARKET SHARE OF MAJOR PLAYERS (2009)
FIGURE 10 ULTRASOUND IMAGING APPLICATIONS
FIGURE 11 ULTRASOUND IMAGING MARKET SHARE (2010)
FIGURE 12 MAMMOGRAPHY EQUIPMENT MARKET SHARE (2009)
FIGURE 13 NUCLEAR IMAGING MARKET SHARE (2009)
FIGURE 14 CARDIOVASCULAR DEVICES MARKET SHARE (2009)
FIGURE 15 INTERVENTIONAL CARDIOLOGY MARKET SHARE (2009)
FIGURE 16 ELECTROPHYSIOLOGY MARKET SHARE (2009)
FIGURE 17 CATARACT DEVICES MARKET SHARE (2009)
FIGURE 18 CONTACT LENS COMPANIES MARKET SHARE (2010)
FIGURE 19 MARKET SHARE FOR FIXED OXYGEN CONCENTRATORS
FIGURE 20 MARKET SHARE FOR PORTABLE OXYGEN CONCENTRATORS
FIGURE 21 PULSE OXIMETER MARKET SHARE (2009)
FIGURE 22 ORTHOBIOLOGICS MARKET SHARE (2009)
FIGURE 23 ARTHROSCOPIC DEVICES MARKET SHARE (2009)
FIGURE 24 KEY ORGANIZATIONAL GOALS FOCUSED THROUGH PARTNERSHIP FORMATION
FIGURE 25 MAJOR STRATEGIC FOCUS, BY MARKET PLAYERS, 2009 – 2011
FIGURE 26 MAJOR PLAYERS USING DIFFERENT STRATEGIES TO GROW, 2009 – 2011
Skip to top


Ask Your Question

Global Top 10 Medical Devices Market (2010 - 2015)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: